From lead management to implanted patient management: Indications to lead extraction in pacemaker and cardioverter-defibrillator systems

Expert Review of Medical Devices

Volumn 8, Issue 2, 2011, Pages 235-255

  Diemberger, Igor ^a   Biffi, Mauro ^a   Martignani, Cristian ^a   Boriani, Giuseppe ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

cardioverter defibrillator; cost; cost effectiveness; healthcare system; infection; lead extraction; pacemaker

Indexed keywords

CARDIOVERTER-DEFIBRILLATOR; COHORT STUDIES; HEALTHCARE SYSTEM; INFECTION; LEAD MANAGEMENT; LONG-TERM STRATEGY; PATIENT MANAGEMENT; PROSPECTIVE EVALUATION;

BACTERIOLOGY; COST EFFECTIVENESS; DEFIBRILLATORS; HEALTH CARE;

COSTS;

CIPROFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; HEPARIN; LINEZOLID; WARFARIN;

ANTIBIOTIC THERAPY; ARTIFICIAL HEART PACEMAKER; AWARENESS; BLOODSTREAM INFECTION; DEFIBRILLATOR; DEVICE INFECTION; ENDOCARDITIS; EXTRACTION; HEART TRANSPLANTATION; HUMAN; PATIENT EDUCATION; PATIENT REFERRAL; PERCUTANEOUS LEAD EXTRACTION; RECURRENT DISEASE; REVIEW; RISK ASSESSMENT; SURVIVAL; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT INDICATION; UPPER EXTREMITY DEEP VEIN THROMBOSIS; VEIN OCCLUSION;

DEFIBRILLATORS, IMPLANTABLE; ELECTRODES, IMPLANTED; EQUIPMENT FAILURE; HUMANS; PACEMAKER, ARTIFICIAL; PATIENT CARE MANAGEMENT; PROSTHESIS-RELATED INFECTIONS;

EID: 79952596467     PISSN: 17434440     EISSN: 17452422     Source Type: Journal    
DOI: 10.1586/erd.10.80     Document Type: Review

References (199)

1. Helguera ME, Maloney JD, Pinski SL, Woscoboinik JR, Wilkoff BL, Castle LW. Long-term performance of endocardial pacing leads. Pacing Clin. Electrophysiol. 17, 56-64 (1994). (Pubitemid 24048547)
2. Robboy SJ, Harthorne JW, Leinbach RC, Sanders CA, Austen WG. Autopsy findings with permanent pervenous pacemakers. Circulation 39, 495-501 (1969).
3. Bongiorni MG, Di Cori A, Soldati E et al. Intracardiac echocardiography in patients with pacing and defibrillating leads: a feasibility study. Echocardiography 25, 632-638 (2008). (Pubitemid 351861993)
4. Bongiorni MG, Zucchelli G, Soldati E et al. Usefulness of mechanical transvenous dilation and location of areas of adherence in patients undergoing coronary sinus lead extraction. Europace 9, 69-73 (2007). (Pubitemid 46157960)
5. Smith HJ, Fearnot NE, Byrd CL. Where does scar tissue form to inhibit extraction of chronic pacemaker leads? J. Am. Coll. Cardiol. 19, 148A (1992).
6. Smith MC, Love CJ. Extraction of transvenous pacing and ICD leads. Pacing Clin. Electrophysiol. 31, 736-752 (2008). (Pubitemid 351749317)
7. Wilkoff BL, Love CJ, Byrd CL et al. Transvenous lead extraction: Heart Rhythm Society expert consensus on facilities, training, indications, and patient management: this document was endorsed by the American Heart Association (AHA). Heart Rhythm 6, 1085-1104 (2009).
8. Kennergren C, Bjurman C, Wiklund R, Gabel J. A single-centre experience of over one thousand lead extractions. Europace 11, 612-617 (2009).
9. Bracke FA, Meijer A, van Gelder LM. Lead extraction for device related infections: a single-centre experience. Europace 6, 243-247 (2004). (Pubitemid 38950170)
10. Bongiorni MG, Soldati E, Zucchelli G et al. Transvenous removal of pacing and implantable cardiac defibrillating leads using single sheath mechanical dilatation and multiple venous approaches: high success rate and safety in more than 2000 leads. Eur. Heart J. 29, 2886-2893 (2008).
11. Neuzil P, Taborsky M, Rezek Z et al. Pacemaker and ICD lead extraction with electrosurgical dissection sheaths and standard transvenous extraction systems: results of a randomized trial. Europace 9, 98-104 (2007). (Pubitemid 46237972)
12. Wilkoff BL, Byrd CL, Love CJ et al. Pacemaker lead extraction with the laser sheath: results of the Pacing Lead Extraction with the Excimer Sheath (PLEXES) trial. J. Am. Coll. Cardiol. 33, 1671-1676 (1999).
13. Kennergren C, Bucknall CA, Butter C et al. Laser-assisted lead extraction: the European experience. Europace 9, 651-656 (2007). (Pubitemid 47263797)
14. Bracke FA. Yes we can! But should we? Lead extraction for superfluous pacemaker and implanted cardioverter- defibrillator leads. Europace 11, 546-547 (2009).
15. Califf RM, Fowler V Jr, Cabell CH, Corey GR. Novel approaches to clinical trials: device-related infections. Am. Heart J. 147, 599-604 (2004). (Pubitemid 38900444)
16. Rahimtoola SH. The next generation of prosthetic heart valves needs a proven track record of patient outcomes at > or =15 to 20 years. J. Am. Coll. Cardiol. 42, 1720-1721 (2003). (Pubitemid 37433647)
17. Schaff H, Carrel T, Steckelberg JM, Grunkemeier GL, Holubkov R. Artificial Valve Endocarditis Reduction Trial (AVERT): protocol of a multicenter randomized trial. J. Heart Valve Dis. 8, 131-139 (1999) (Pubitemid 29166802)
18. Klug D, Lacroix D, Savoye C et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 95, 2098-2107 (1997). (Pubitemid 27184278)
19. Conklin EF, Giannelli S Jr, Ayres SM, Mueller HS, Grace WJ. Prevention of pacemaker infections. NY State J. Med. 73, 2675-2677 (1973).
20. Bluhm G. Pacemaker infections. A clinical study with special reference to prophylactic use of some isoxazolyl penicillins. Acta Med. Scand. 699, 1-62 (1985).
21. Aggarwal RK, Connelly DT, Ray SG, Ball J, Charles RG. Early complications of permanent pacemaker implantation: no difference between dual and single chamber systems. Br. Heart J. 73, 571-575 (1995).
22. Catanchin A, Murdock CJ, Athan E. Pacemaker infections: a 10-year experience. Heart Lung Circ. 16, 434-439 (2007). (Pubitemid 350091403)
23. Kiviniemi MS, Pirnes MA, Eranen HJ, Kettunen RV, Hartikainen JE. Complications related to permanent pacemaker therapy. Pacing Clin. Electrophysiol. 22, 711-720 (1999). (Pubitemid 29244984)
24. Arber N, Pras E, Copperman Y et al. Pacemaker endocarditis. Report of 44 cases and review of the literature. Medicine (Baltimore) 73, 299-305 (1994).
25. Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med. 346, 877-883 (2002). (Pubitemid 34984635)
26. Mela T, McGovern BA, Garan H et al. Long-term infection rates associated with the pectoral versus abdominal approach to cardioverter- defibrillator implants. Am. J. Cardiol. 88, 750-753 (2001).
27. del Rio A, Anguera I, Miro JM et al. Surgical treatment of pacemaker and defibrillator lead endocarditis: the impact of electrode lead extraction on outcome. Chest 124, 1451-1459 (2003). (Pubitemid 37290057)
28. Duval X, Selton-Suty C, Alla F et al. Endocarditis in patients with a permanent pacemaker: a 1-year epidemiological survey on infective endocarditis due to valvular and/or pacemaker infection. Clin. Infect. Dis. 39, 68-74 (2004). (Pubitemid 38879551)
29. Klug D, Wallet F, Lacroix D et al. Local symptoms at the site of pacemaker implantation indicate latent systemic infection. Heart 90, 882-886 (2004). (Pubitemid 39005933)
30. Anselmino M, Vinci M, Comoglio C et al. Bacteriology of infected extracted pacemaker and ICD leads. J. Cardiovasc. Med. (Hagerstown) 10, 693-698 (2009).
31. Voigt A, Shalaby A, Saba S. Rising rates of cardiac rhythm management device infections in the United States: 1996 through 2003. J. Am. Coll. Cardiol. 48, 590-591 (2006). (Pubitemid 44093958)
32. Cabell CH, Heidenreich PA, Chu VH et al. Increasing rates of cardiac device infections among Medicare beneficiaries: 1990-1999. Am. Heart J. 147, 582-586 (2004). (Pubitemid 38900441)
33. Boriani G, Rapezzi C, Diemberger I et al. Trial-generated profiles for implantation of electrical devices in outpatients with heart failure: real-world prevalence and 1-year outcome. J. Eval. Clin. Pract. 16, 82-91 (2010).
34. Uslan DZ, Sohail MR, St Sauver JL et al. Permanent pacemaker and implantable cardioverter defibrillator infection: a population-based study. Arch. Intern. Med. 167, 669-675 (2007). (Pubitemid 46598459)
35. Maisel WH. Pacemaker and ICD generator reliability: meta-analysis of device registries. JAMA 295, 1929-1934 (2006).
36. Maisel WH, Moynahan M, Zuckerman BD et al. Pacemaker and ICD generator malfunctions: analysis of Food and Drug Administration annual reports. JAMA 295, 1901-1906 (2006).
37. Maisel WH, Sweeney MO, Stevenson WG, Ellison KE, Epstein LM. Recalls and safety alerts involving pacemakers and implantable cardioverter-defibrillator generators. JAMA 286, 793-799 (2001). (Pubitemid 33015572)
38. Boriani G, Biffi M, Branzi A, Mininno A, Sigliano R. Benefits in projected pacemaker longevity and in pacing related costs conferred by automatic threshold tracking. Pacing Clin. Electrophysiol. 23, 1783-1787 (2000).
39. Biffi M, Bertini M, Saporito D et al. Actual pacemaker longevity: the benefit of stimulation by automatic capture verification. Pacing Clin. Electrophysiol. 33(7), 873-881 (2010).
40. Das MK, Dandamudi G, Steiner HA. Modern pacemakers: hope or hype? Pacing Clin. Electrophysiol. 32, 1207-1221 (2009).
41. Gould PA, Krahn AD. Complications associated with implantable cardioverter- defibrillator replacement in response to device advisories. JAMA 295, 1907-1911 (2006).
42. Hauser R, Hayes D, Parsonnet V et al. Feasibility and initial results of an Internet-based pacemaker and ICD pulse generator and lead registry. Pacing Clin. Electrophysiol. 24, 82-87 (2001). (Pubitemid 32165734)
43. Hauser RG. The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators. J. Am. Coll. Cardiol. 45, 2022-2025 (2005). (Pubitemid 40814126)
44. Hauser RG, Hayes DL, Epstein AE et al. Multicenter experience with failed and recalled implantable cardioverter-defibrillator pulse generators. Heart Rhythm 3, 640-644 (2006).
45. Parsonnet V, Driller J, Cook D, Rizvi SA. Thirty-one years of clinical experience with 'nuclear-powered' pacemakers. Pacing Clin. Electrophysiol. 29, 195-200 (2006).
46. Knops P, Theuns DA, Res JC, Jordaens L. Analysis of implantable defibrillator longevity under clinical circumstances: implications for device selection. Pacing Clin. Electrophysiol. 32, 1276-1285 (2009).
47. Brunner M, Olschewski M, Geibel A, Bode C, Zehender M. Long-term survival after pacemaker implantation. Prognostic importance of gender and baseline patient characteristics. Eur. Heart J. 25, 88-95 (2004). (Pubitemid 38055597)
48. Kindermann M, Schwaab B, Berg M, Frohlig G. Longevity of dual chamber pacemakers: device and patient related determinants. Pacing Clin. Electrophysiol. 24, 810-815 (2001). (Pubitemid 32437021)
49. Love CJ, Wilkoff BL, Byrd CL et al. Recommendations for extraction of chronically implanted transvenous pacing and defibrillator leads: indications, facilities, training. North American Society of Pacing and Electrophysiology Lead Extraction Conference Faculty. Pacing Clin. Electrophysiol. 23, 544-551 (2000).
50. Klug D, Balde M, Pavin D et al. Risk factors related to infections of implanted pacemakers and cardioverter-defibrillators: results of a large prospective study. Circulation 116, 1349-1355 (2007). (Pubitemid 47417560)
51. Uslan DZ, Baddour LM. Cardiac device infections: getting to the heart of the matter. Curr. Opin. Infect. Dis. 19, 345-348 (2006). (Pubitemid 43982506)
52. Chua JD, Wilkoff BL, Lee I, Juratli N, Longworth DL, Gordon SM. Diagnosis and management of infections involving implantable electrophysiologic cardiac devices. Ann. Intern. Med. 133, 604-608 (2000)
53. Chambers ST. Diagnosis and management of staphylococcal infections of pacemakers and cardiac defibrillators. Intern. Med. J. 35(Suppl. 2), S63-S71 (2005). (Pubitemid 44933540)
54. Baman TS, Gupta SK, Valle JA, Yamada E. Risk factors for mortality in patients with cardiac device-related infection. Circ. Arrhythm. Electrophysiol. 2, 129-134 (2009).
55. Sohail MR, Uslan DZ, Khan AH et al. Management and outcome of permanent pacemaker and implantable cardioverter-defibrillator infections. J. Am. Coll. Cardiol. 49, 1851-1859 (2007). (Pubitemid 46661104)
56. Sohail MR, Khan AH, Holmes DR Jr, Wilson WR, Steckelberg JM, Baddour LM. Infectious complications of percutaneous vascular closure devices. Mayo Clin. Proc. 80, 1011-1015 (2005). (Pubitemid 41099386)
57. Baddour LM, Epstein AE, Erickson CC et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association. Circulation 121, 458-477 (2010).
58. Karchmer AW, Longworth DL. Infections of intracardiac devices. Cardiol. Clin. 21, 253-271, vii (2003).
59. Field ME, Jones SO, Epstein LM. How to select patients for lead extraction. Heart Rhythm 4, 978-985 (2007). (Pubitemid 46959211)
60. Corey GR, Lalani T. Risk of intravascular cardiac device infections in patients with bacteraemia: impact on device removal. Int. J. Antimicrob. Agents 32(Suppl. 1), S26-S29 (2008).
61. Chamis AL, Peterson GE, Cabell CH et al. Staphylococcus aureus bacteremia in patients with permanent pacemakers or implantable cardioverter- defibrillators. Circulation 104, 1029-1033 (2001). (Pubitemid 32803880)
62. Uslan DZ, Sohail MR, Friedman PA et al. Frequency of permanent pacemaker or implantable cardioverter-defibrillator infection in patients with Gram-negative bacteremia. Clin. Infect. Dis. 43, 731-736 (2006). (Pubitemid 44330736)
63. Sopena B, Crespo M, Beiras X et al. Individualized management of bacteraemia in patients with a permanent endocardial pacemaker. Clin. Microbiol. Infect. 16, 274-280 (2010).
64. Baddour LM, Bettmann MA, Bolger AF et al. Nonvalvular cardiovascular device-related infections. Clin. Infect. Dis. 38, 1128-1130 (2004). (Pubitemid 38951259)
65. Tascini C, Bongiorni MG, Leonildi A et al. Pacemaker endocarditis with pulmonary cavitary lesion due to Scedosporium prolificans. J. Chemother. 18, 667-669 (2006). (Pubitemid 46045401)
66. Klug D, Wallet F, Kacet S, Courcol RJ. Detailed bacteriologic tests to identify the origin of transvenous pacing system infections indicate a high prevalence of multiple organisms. Am. Heart J. 149, 322-328 (2005). (Pubitemid 40348542)
67. Karchmer AW, Longworth DL. Infections of intracardiac devices. Infect. Dis. Clin. North Am 16, 477-505, xii (2002). (Pubitemid 34663647)
68. Lewis AB, Hayes DL, Holmes DR Jr, Vlietstra RE, Pluth JR, Osborn MJ. Update on infections involving permanent pacemakers. Characterization and management. J. Thorac. Cardiovasc. Surg. 89, 758-763 (1985). (Pubitemid 16241970)
69. Da Costa A, Kirkorian G, Cucherat M et al. Antibiotic prophylaxis for permanent pacemaker implantation: a meta-analysis. Circulation 97, 1796-1801 (1998). (Pubitemid 28213623)
70. de Oliveira JC, Martinelli M, Nishioka SA et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter- defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ. Arrhythm. Electrophysiol. 2, 29-34 (2009).
71. Da Costa A, Lelievre H, Kirkorian G et al. Role of the preaxillary flora in pacemaker infections: a prospective study. Circulation 97, 1791-1795 (1998). (Pubitemid 28213622)
72. Soongswang J, Nana A, Laohaprasittiporn D et al. Permanent cardiac pacing in pediatrics : experience in Thailand. J. Med. Assoc. Thai. 88(Suppl. 8), S106-S114 (2005). (Pubitemid 43175629)
73. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am. J. Infect. Control 27, 520-532 (1999).
74. Centers for Disease Control and Prevention (CDC).Staphylococcus aureus resistant to vancomycin - United States, 2002. MMWR Morb. Mortal. Wkly Rep. 51, 565-567 (2002).
75. Fridkin SK, Hageman J, McDougal LK et al. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997-2001. Clin. Infect. Dis. 36, 429-439 (2003). (Pubitemid 36241308)
76. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J. Antimicrob. Chemother. 40, 135-136 (1997). (Pubitemid 27341646)
77. Furuya EY, Lowy FD. Antimicrobial strategies for the prevention and treatment of cardiovascular infections. Curr. Opin. Pharmacol. 3, 464-469 (2003). (Pubitemid 37221124)
78. Drew RH, Perfect JR, Srinath L, Kurkimilis E, Dowzicky M, Talbot GH. Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study Group. J. Antimicrob. Chemother. 46, 775-784 (2000).
79. Babcock HM, Ritchie DJ, Christiansen E, Starlin R, Little R, Stanley S. Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid. Clin. Infect. Dis. 32, 1373-1375 (2001). (Pubitemid 32405913)
80. Rao N, White GJ. Successful treatment of Enterococcus faecalis prosthetic valve endocarditis with linezolid. Clin. Infect. Dis. 35, 902-904 (2002).
81. Birmingham MC, Rayner CR, Meagher AK, Flavin SM, Batts DH, Schentag JJ. Linezolid for the treatment of multidrug-resistant, Gram-positive infections: experience from a compassionate-use program. Clin. Infect. Dis. 36, 159-168 (2003). (Pubitemid 36143412)
82. Utili R, Durante-Mangoni E, Tripodi MF. Infection of intravascular prostheses: how to treat other than surgery. Int. J. Antimicrob Agents 30(Suppl. 1), S42-S50 (2007).
83. Donlan RM. Biofilms and device-associated infections. Emerg. Infect. Dis. 7, 277-281 (2001). (Pubitemid 32374344)
84. Raad I. Intravascular-catheter-related infections. Lancet 351, 893-898 (1998). (Pubitemid 28121188)
85. Shinefield H, Black S, Fattom A et al. Use of a Staphylococcus aureus conjugate vaccine in patients receiving hemodialysis. N. Engl. J. Med. 346, 491-496 (2002). (Pubitemid 34441740)
86. Chiu WS, Nguyen D. Pacemaker lead extraction in pacemaker endocarditis with lead vegetation: usefulness of transesophageal echocardiography. Can. J. Cardiol. 14, 87-89 (1998). (Pubitemid 28072452)
87. Phibbs B, Marriott HJ. Complications of permanent transvenous pacing. N. Engl. J. Med. 312, 1428-1432 (1985). (Pubitemid 15083661)
88. Molina JE. Undertreatment and overtreatment of patients with infected antiarrhythmic implantable devices. Ann. Thorac. Surg. 63, 504-509 (1997). (Pubitemid 27084581)
89. Rundstrom H, Kennergren C, Andersson R, Alestig K, Hogevik H. Pacemaker endocarditis during 18 years in Goteborg. Scand. J. Infect. Dis. 36, 674-679 (2004).
90. Lee JH, Geha AS, Rattehalli NM et al. Salvage of infected ICDs: management without removal. Pacing Clin. Electrophysiol. 19, 437-442 (1996). (Pubitemid 26119097)
91. Hurst LN, Evans HB, Windle B, Klein GJ. The salvage of infected cardiac pacemaker pockets using a closed irrigation system. Pacing Clin. Electrophysiol. 9, 785-792 (1986). (Pubitemid 17214381)
92. Garcia-Rinaldi R, Revuelta JM, Bonnington L, Soltero-Harrington L. The exposed cardiac pacemaker. Treatment by subfascial pocket relocation. J. Thorac. Cardiovasc. Surg. 89, 136-141 (1985). (Pubitemid 16237669)
93. Rettig G, Doenecke P, Sen S, Volkmer I, Bette L. Complications with retained transvenous pacemaker electrodes. Am. Heart J. 98, 587-594 (1979). (Pubitemid 10210603)
94. Vogt PR, Sagdic K, Lachat M, Candinas R, von Segesser LK, Turina MI. Surgical management of infected permanent transvenous pacemaker systems: ten year experience. J. Card. Surg. 11, 180-186 (1996). (Pubitemid 26328331)
95. Parry G, Goudevenos J, Jameson S, Adams PC, Gold RG. Complications associated with retained pacemaker leads. Pacing Clin. Electrophysiol. 14, 1251-1257 (1991).
96. Yamada M, Takeuchi S, Shiojiri Y et al. Surgical lead-preserving procedures for pacemaker pocket infection. Ann. Thorac. Surg. 74, 1494-1499; discussion 1499 (2002). (Pubitemid 35222628)
97. Kolker AR, Redstone JS, Tutela JP. Salvage of exposed implantable cardiac electrical devices and lead systems with pocket change and local flap coverage. Ann. Plast. Surg. 59, 26-29; discussion 30 (2007). (Pubitemid 46987970)
98. Samuels LE, Samuels FL, Kaufman MS, Morris RJ, Brockman SK. Management of infected implantable cardiac defibrillators. Ann. Thorac. Surg. 64, 1702-1706 (1997). (Pubitemid 28066541)
99. Griffith MJ, Mounsey JP, Bexton RS, Holden MP. Mechanical, but not infective, pacemaker erosion may be successfully managed by re-implantation of pacemakers. Br. Heart J. 71, 202-205 (1994). (Pubitemid 24092708)
100. Jara FM, Toledo-Pereyra L, Lewis JW Jr, Magilligan DJ Jr. The infected pacemaker pocket. J. Thorac. Cardiovasc. Surg. 78, 298-300 (1979). (Pubitemid 10218548)
101. Taylor RL, Cohen DJ, Widman LE, Chilton RJ, O'Rourke RA. Infection of an implantable cardioverter defibrillator: management without removal of the device in selected cases. Pacing Clin. Electrophysiol. 13, 1352-1355 (1990). (Pubitemid 20383397)
102. Dy Chua J, Abdul-Karim A, Mawhorter S et al. The role of swab and tissue culture in the diagnosis of implantable cardiac device infection. Pacing Clin. Electrophysiol. 28, 1276-1281 (2005). (Pubitemid 43951387)
103. Bracke FA, Meijer A, van Gelder LM. Pacemaker lead complications: when is extraction appropriate and what can we learn from published data? Heart 85, 254-259 (2001).
104. Bohm A, Banyai F, Preda I, Zamolyi K. The treatment of septicemia in pacemaker patients. Pacing Clin. Electrophysiol. 19, 1105-1111 (1996). (Pubitemid 26266062)
105. Cacoub P, Leprince P, Nataf P et al. Pacemaker infective endocarditis. Am. J. Cardiol. 82, 480-484 (1998). (Pubitemid 28389947)
106. Mylonakis E, Calderwood SB. Infective endocarditis in adults. N. Engl. J. Med. 345, 1318-1330 (2001).
107. Darouiche RO. Treatment of infections associated with surgical implants. N. Engl. J. Med. 350, 1422-1429 (2004). (Pubitemid 38419996)
108. Baddour LM, Bettmann MA, Bolger AF et al. Nonvalvular cardiovascular device-related infections. Circulation 108, 2015-2031 (2003). (Pubitemid 37296549)
109. Massoure PL, Reuter S, Lafitte S et al. Pacemaker endocarditis: clinical features and management of 60 consecutive cases. Pacing Clin. Electrophysiol. 30, 12-19 (2007). (Pubitemid 46114923)
110. Henrikson CA, Brinker JA. How to prevent, recognize, and manage complications of lead extraction. Part I: avoiding lead extraction - infectious issues. Heart Rhythm 5, 1083-1087 (2008).
111. Henrikson CA, Brinker JA. How to prevent, recognize, and manage complications of lead extraction. Part II: avoiding lead extraction - noninfectious issues. Heart Rhythm 5, 1221-1223 (2008).
112. Golzio PG, Vinci M, Anselmino M et al. Accuracy of swabs, tissue specimens, and lead samples in diagnosis of cardiac rhythm management device infections. Pacing Clin. Electrophysiol. 32(Suppl. 1), S76-S80 (2009).
113. Bensimhon L, Lavergne T, Hugonnet F et al. Whole-body 18F-FDG PET imaging for the diagnosis of pacemaker or implantable cardioverter defibrillator infection. A preliminary prospective study. Clin. Microbiol. Infect. DOI: 10.1111/j.1469-0691.2010.03312.x (2010) (Epub ahead of print).
114. Marijon E, De Guillebon M, Bordachar P et al. Safety of deferring the reimplantation of pacing systems after their removal for infectious complications in selected patients: a 1-year follow-up study. J. Cardiovasc. Electrophysiol. 21, 540-544 (2010)
115. Martinelli M, Costa R, Nishioka S et al. Criteria for pacemaker explant in patients without a precise indication for pacemaker implantation. Pacing Clin. Electrophysiol. 25, 272-277 (2002). (Pubitemid 34274406)
116. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service. Am. J. Med. 96, 200-209 (1994).
117. Li JS, Sexton DJ, Mick N et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin. Infect. Dis. 30, 633-638 (2000).
118. Victor F, De Place C, Camus C et al. Pacemaker lead infection: echocardiographic features, management, and outcome. Heart 81, 82-87 (1999). (Pubitemid 29113209)
119. Lauck G, Hagendorff A, Omran H. Sessile structures on implanted leads of cardiac pacemaker. Eur. Heart J. 15, 58 (1994).
120. Lo R, D'Anca M, Cohen T, Kerwin T. Incidence and prognosis of pacemaker lead-associated masses: a study of 1,569 transesophageal echocardiograms. J. Invasive Cardiol. 18, 599-601 (2006). (Pubitemid 46088085)
121. Dumont E, Camus C, Victor F et al. Suspected pacemaker or defibrillator transvenous lead infection. Prospective assessment of a TEE-guided therapeutic strategy. Eur. Heart J. 24, 1779-1787 (2003). (Pubitemid 37236868)
122. Kalman JM, Olgin JE, Karch MR, Lesh MD. Use of intracardiac echocardiography in interventional electrophysiology. Pacing Clin. Electrophysiol. 20, 2248-2262 (1997). (Pubitemid 27407372)
123. Ren JF, Marchlinski FE. Utility of intracardiac echocardiography in left heart ablation for tachyarrhythmias. Echocardiography 24, 533-540 (2007). (Pubitemid 46643043)
124. Nanda NC, Miller AP. Principles of intracardiac echocardiography. J. Interv. Card. Electrophysiol. 13(Suppl. 1), 7-10 (2005). (Pubitemid 41225151)
125. Dalal A, Asirvatham SJ, Chandrasekaran K, Seward JB, Tajik AJ. Intracardiac echocardiography in the detection of pacemaker lead endocarditis. J. Am. Soc. Echocardiogr. 15, 1027-1028 (2002).
126. Kolodner DQ, Shimbo D, Magnano AR. Intracardiac echocardiography in the diagnosis of prosthetic valve endocarditis. Heart 93, 1120 (2007). (Pubitemid 47310994)
127. Grammes JA, Schulze CM, Al-Bataineh M et al. Percutaneous pacemaker and implantable cardioverter-defibrillator lead extraction in 100 patients with intracardiac vegetations defined by transesophageal echocardiogram. J. Am. Coll. Cardiol. 55, 886-894 (2010).
128. Meier-Ewert HK, Gray ME, John RM. Endocardial pacemaker or defibrillator leads with infected vegetations: a single-center experience and consequences of transvenous extraction. Am. Heart J. 146, 339-344 (2003). (Pubitemid 36951781)
129. Verma A, Wilkoff BL. Intravascular pacemaker and defibrillator lead extraction: a state-of-the-art review. Heart Rhythm 1, 739-745 (2004). (Pubitemid 40028783)
130. Ruttmann E, Hangler HB, Kilo J et al. Transvenous pacemaker lead removal is safe and effective even in large vegetations: an analysis of 53 cases of pacemaker lead endocarditis. Pacing Clin. Electrophysiol. 29, 231-236 (2006). (Pubitemid 43881397)
131. Mugge A, Daniel WG, Frank G, Lichtlen PR. Echocardiography in infective endocarditis: reassessment of prognostic implications of vegetation size determined by the transthoracic and the transesophageal approach. J. Am. Coll. Cardiol. 14, 631-638 (1989). (Pubitemid 19229338)
132. Robbins MJ, Frater RW, Soeiro R, Frishman WH, Strom JA. Influence of vegetation size on clinical outcome of right-sided infective endocarditis. Am. J. Med. 80, 165-171 (1986). (Pubitemid 16140760)
133. Nguyen KT, Neese P, Kessler DJ. Successful laser-assisted percutaneous extraction of four pacemaker leads associated with large vegetations. Pacing Clin. Electrophysiol. 23, 1260-1262 (2000). (Pubitemid 30658518)
134. Calton R, Cameron D, Cusimano RJ, Merchant N, Chauhan V. Successful laser-assisted removal of an infected ICD lead with a large vegetation. Pacing Clin. Electrophysiol. 29, 910-913 (2006). (Pubitemid 44222147)
135. Maloney JD, Maloney JD 3rd. Vegetation size marker for extraction technique? J. Am. Coll. Cardiol. 55, 895-897 (2010).
136. van Erven L, Morgan JM. Attitude towards redundant leads and the practice of lead extractions: a European survey. Europace 12, 275-276 (2010).
137. Henrikson CA, Zhang K, Brinker JA. A survey of the practice of lead extraction in the United States. Pacing Clin. Electrophysiol. 33, 721-726 (2010).
138. Xu W, Moore HJ, Karasik PE, Franz MR, Singh SN, Fletcher RD. Management strategies when implanted cardioverter defibrillator leads fail: survey findings. Pacing Clin. Electrophysiol. 32, 1130-1141 (2009).
139. Suga C, Hayes DL, Hyberger LK, Lloyd MA. Is there an adverse outcome from abandoned pacing leads? J. Intrv. Card. Electrophysiol. 4, 493-499 (2000).
140. Byrd CL, Wilkoff BL, Love CJ, Sellers TD, Reiser C. Clinical study of the laser sheath for lead extraction: the total experience in the United States. Pacing Clin. Electrophysiol. 25, 804-808 (2002). (Pubitemid 34521638)
141. Roux JF, Page P, Dubuc M et al. Laser lead extraction: predictors of success and complications. Pacing Clin. Electrophysiol. 30, 214-220 (2007). (Pubitemid 46333677)
142. Stirbys P. Removable or nonremovable endocardial electrodes: do not accept erroneous conclusions. Pacing Clin. Electrophysiol. 14, 858-859 (1991).
143. Gibson TC, Davidson RC, DeSilvey DL. Presumptive tricuspid valve malfunction induced by a pacemaker lead: a case report and review of the literature. Pacing Clin. Electrophysiol. 3, 88-95 (1980). (Pubitemid 10113025)
144. Wazni O, Epstein LM, Carrillo RG et al. Lead extraction in the contemporary setting: the LExICon study: an observational retrospective study of consecutive laser lead extractions. J. Am. Coll. Cardiol. 55, 579-586 (2010).
145. Marijon E, Boveda S, De Guillebon M et al. Contributions of advanced techniques to the success and safety of transvenous leads extraction. Pacing Clin. Electrophysiol. 32(Suppl. 1), S38-S41 (2009).
146. Parkash R, Crystal E, Bashir J et al. Complications associated with revision of Sprint Fidelis leads: report from the Canadian Heart Rhythm Society Device Advisory Committee. Circulation 121, 2384-2387 (2010).
147. Bordachar P, Defaye P, Peyrouse E et al. Extraction of old pacemaker or cardioverter-defibrillator leads by laser sheath versus femoral approach. Circ. Arrhythm. Electrophysiol. 3, 319-323 (2010).
148. de Cock CC, Vinkers M, Van Campe LC, Verhorst PM, Visser CA. Long-term outcome of patients with multiple (> or = 3) noninfected transvenous leads: a clinical and echocardiographic study. Pacing Clin. Electrophysiol. 23, 423-426 (2000). (Pubitemid 30226907)
149. Glikson M, Suleiman M, Luria DM et al. Do abandoned leads pose risk to implantable cardioverter-defibrillator patients? Heart Rhythm 6, 65-68 (2009).
150. Zerbe F, Ponizynski A, Dyszkiewicz W, Ziemianski A, Dziegielewski T, Krug H. Functionless retained pacing leads in the cardiovascular system. A complication of pacemaker treatment. Br. Heart J. 54, 76-79 (1985). (Pubitemid 15069204)
151. Blair TP, Seibel J Jr, Goodreau J, Groves R, Ashworth HE, Baker WP. Surgical relief of thrombotic superior vena cava obstruction caused by endocardial pacing catheter. Ann. Thorac. Surg. 33, 511-515 (1982). (Pubitemid 12116005)
152. Epstein AE, DiMarco JP, Ellenbogen KA et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation 117, e350-e408 (2008). (Pubitemid 351771339)
153. Eckstein J, Koller MT, Zabel M et al. Necessity for surgical revision of defibrillator leads implanted long-term: causes and management. Circulation 117, 2727-2733 (2008). (Pubitemid 351770453)
154. Jones SO 4th, Eckart RE, Albert CM, Epstein LM. Large, single-center, single-operator experience with transvenous lead extraction: outcomes and changing indications. Heart Rhythm 5, 520-525 (2008).
155. Borek PP, Wilkoff BL. Pacemaker and ICD leads: strategies for long-term management. J. Interv. Card. Electrophysiol. 23, 59-72 (2008).
156. Haqqani HM, Mond HG. The implantable cardioverter-defibrillator lead: principles, progress, and promises. Pacing Clin. Electrophysiol. 32, 1336-1353 (2009).
157. Goette A, Cantu F, van Erven L et al. Performance and survival of transvenous defibrillation leads: need for a European data registry. Europace 11, 31-34 (2009).
158. Gunderson BD, Patel AS, Bounds CA, Shepard RK, Wood MA, Ellenbogen KA. An algorithm to predict implantable cardioverter-defibrillator lead failure. J. Am. Coll. Cardiol. 44, 1898-1902 (2004). (Pubitemid 39424093)
159. Vollmann D, Erdogan A, Himmrich E et al. Patient Alert to detect ICD lead failure: efficacy, limitations, and implications for future algorithms. Europace 8, 371-376 (2006). (Pubitemid 43941671)
160. Maisel WH, Hauser RG, Hammill SC et al. Recommendations from the Heart Rhythm Society Task Force on Lead Performance Policies and Guidelines: developed in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA).Heart Rhythm 6, 869-885 (2009).
161. Maisel WH, Kramer DB. Implantable cardioverter-defibrillator lead performance. Circulation 117, 2721-2723 (2008). (Pubitemid 351770451)
162. Gradaus R, Breithardt G, Bocker D. ICD leads: design and chronic dysfunctions. Pacing Clin. Electrophysiol. 26, 649-657 (2003). (Pubitemid 36403352)
163. Kleemann T, Becker T, Doenges K et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverter- defibrillators over a period of >10 years. Circulation 115, 2474-2480 (2007). (Pubitemid 46763220)
164. Grunkemeier GL, Anderson RP, Miller DC, Starr A. Time-related analysis of nonfatal heart valve complications: cumulative incidence (actual) versus Kaplan-Meier (actuarial).Circulation 96, II-70-74; discussion II-74-75 (1997).
165. Duray GZ, Schmitt J, Cicek-Hartvig S, Hohnloser SH, Israel CW. Complications leading to surgical revision in implantable cardioverter defibrillator patients: comparison of patients with single-chamber, dual-chamber, and biventricular devices. Europace 11, 297-302 (2009).
166. Cygankiewicz I, Gillespie J, Zareba W et al. Predictors of long-term mortality in Multicenter Automatic Defibrillator Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillators. Heart Rhythm 6, 468-473 (2009).
167. Lloyd-Jones D, Adams RJ, Brown TM et al. Heart disease and stroke statistics - 2010 update: a report from the American Heart Association. Circulation 121, e46-e215 (2010).
168. Lloyd-Jones D, Adams R, Carnethon M et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119, 480-486 (2009).
169. Moss AJ, Hall WJ, Cannom DS et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N. Engl. J. Med. 361, 1329-1338 (2009).
170. Burke MC. Percutaneous extraction of coronary sinus vein and branch leads. Heart Rhythm 5, 491-495 (2008).
171. De Martino G, Orazi S, Bisignani G et al. Safety and feasibility of coronary sinus left ventricular leads extraction: a preliminary report. J. Interv. Card. Electrophysiol. 13, 35-38 (2005). (Pubitemid 40864136)
172. Kawanishi DT, Brinker JA, Reeves R et al. Kaplan-Meier analysis of freedom from extraction or death in patients with an Accufix J retention wire atrial permanent pacemaker lead: a potential management tool. Pacing Clin. Electrophysiol. 21, 2318-2321 (1998).
173. Maytin M, Love CJ, Fischer A et al. Multicenter experience with extraction of the Sprint Fidelis implantable cardioverter- defibrillator lead. J. Am. Coll. Cardiol. 56, 646-650 (2010)
174. Al-Khatib SM, Sanders GD, Mark DB et al. Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004. Am. Heart J. 149, 1020-1034 (2005). (Pubitemid 40848146)
175. Packer DL, Prutkin JM, Hellkamp AS et al. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation 120, 2170-2176 (2009).
176. Mathur G, Stables RH, Heaven D et al. Cardiac pacemaker lead extraction using conventional techniques: a single centre experience. Int. J. Cardiol. 91, 215-219 (2003). (Pubitemid 38373447)
177. Hauser RG. A better method for preventing adverse clinical events caused by implantable cardioverter-defibrillator lead fractures? Circulation 118, 2117-2119 (2008).
178. Spiezia L, Simioni P. Upper extremity deep vein thrombosis. Intern. Emerg. Med. 5, 103-109 (2010).
179. Rozmus G, Daubert JP, Huang DT, Rosero S, Hall B, Francis C. Venous thrombosis and stenosis after implantation of pacemakers and defibrillators. J. Interv. Card. Electrophysiol. 13, 9-19 (2005). (Pubitemid 40864133)
180. Bracke F, Meijer A, Van Gelder B. Venous occlusion of the access vein in patients referred for lead extraction: influence of patient and lead characteristics. Pacing Clin. Electrophysiol. 26, 1649-1652 (2003). (Pubitemid 36936737)
181. Antonelli D, Turgeman Y, Kaveh Z, Artoul S, Rosenfeld T. Short-term thrombosis after transvenous permanent pacemaker insertion. Pacing Clin. Electrophysiol. 12, 280-282 (1989). (Pubitemid 19145881)
182. Goto Y, Abe T, Sekine S, Sakurada T. Long-term thrombosis after transvenous permanent pacemaker implantation. Pacing Clin. Electrophysiol. 21, 1192-1195 (1998). (Pubitemid 28270050)
183. Marx E, Schulte HD, Balau J, Buysch KA. Phlebographic and clinical early and late findings in transvenously implanted pacemaker electrodes. Z. Kreislaufforsch. 61, 115-123 (1972).
184. Mitrovic V, Thormann J, Schlepper M, Neuss H. Thrombotic complications with pacemakers. Int. J. Cardiol. 2, 363-374 (1983). (Pubitemid 13180711)
185. Pauletti M, Di Ricco G, Solfanelli S, Marini C, Contini C, Giuntini C. Venous obstruction in permanent pacemaker patients: an isotopic study. Pacing Clin. Electrophysiol. 4, 36-42 (1981). (Pubitemid 11174551)
186. Sticherling C, Chough SP, Baker RL et al. Prevalence of central venous occlusion in patients with chronic defibrillator leads. Am. Heart J. 141, 813-816 (2001). (Pubitemid 32378492)
187. Lickfett L, Bitzen A, Arepally A et al. Incidence of venous obstruction following insertion of an implantable cardioverter defibrillator. A study of systematic contrast venography on patients presenting for their first elective ICD generator replacement. Europace 6, 25-31 (2004). (Pubitemid 38949864)
188. Zuber M, Huber P, Fricker U, Buser P, Jager K. Assessment of the subclavian vein in patients with transvenous pacemaker leads. Pacing Clin. Electrophysiol. 21, 2621-2630 (1998). (Pubitemid 29031408)
189. Bracke FA, Meijer A, Van Gelder LM. Symptomatic occlusion of the access vein after pacemaker or ICD lead extraction. Heart 89, 1348-1349 (2003). (Pubitemid 37311104)
190. Da Costa SS, Scalabrini Neto A, Costa R, Caldas JG, Martinelli Filho M. Incidence and risk factors of upper extremity deep vein lesions after permanent transvenous pacemaker implant: a 6-month follow-up prospective study. Pacing Clin. Electrophysiol. 25, 1301-1306 (2002).
191. Byrd CL. Safe introducer technique for pacemaker lead implantation. Pacing Clin. Electrophysiol. 15, 262-267 (1992).
192. Myers MR, Parsonnet V, Bernstein AD. Extraction of implanted transvenous pacing leads: a review of a persistent clinical problem. Am. Heart J. 121, 881-888 (1991).
193. Oginosawa Y, Abe H, Nakashima Y. The incidence and risk factors for venous obstruction after implantation of transvenous pacing leads. Pacing Clin. Electrophysiol. 25, 1605-1611 (2002). (Pubitemid 35398922)
194. Bar-Cohen Y, Berul CI, Alexander ME et al. Age, size, and lead factors alone do not predict venous obstruction in children and young adults with transvenous lead systems. J. Cardiovasc. Electrophysiol. 17, 754-759 (2006).
195. Korkeila PJ, Saraste MK, Nyman KM, Koistinen J, Lund J, Juhani Airaksinen KE. Transesophageal echocardiography in the diagnosis of thrombosis associated with permanent transvenous pacemaker electrodes. Pacing Clin. Electrophysiol. 29, 1245-1250 (2006). (Pubitemid 44707107)
196. Haghjoo M, Nikoo MH, Fazelifar AF, Alizadeh A, Emkanjoo Z, Sadr-Ameli MA. Predictors of venous obstruction following pacemaker or implantable cardioverter- defibrillator implantation: a contrast venographic study on 100 patients admitted for generator change, lead revision, or device upgrade. Europace 9, 328-332 (2007). (Pubitemid 47079254)
197. Costa R, Da Silva KR, Rached R et al. Prevention of venous thrombosis by warfarin after permanent transvenous leads implantation in high-risk patients. Pacing Clin. Electrophysiol. 32(Suppl. 1), S247-S251 (2009).
198. Marrie TJ, Costerton JW. Morphology of bacterial attachment to cardiac pacemaker leads and power packs. J. Clin. Microbiol. 19, 911-914 (1984). (Pubitemid 14105052)
199. Marrie TJ, Nelligan J, Costerton JW. A scanning and transmission electron microscopic study of an infected endocardial pacemaker lead. Circulation 66, 1339-1341 (1982). (Pubitemid 13238856)